ModelEdge

Cyclacel Pharmaceuticals Inc.
CYCC
Filing Type8-K
Filing Date9/11/2025
Updated9/12/25, 4:07 AM

Filing

8-K
Earnings Release

Exhibits

8-KCompleting Asset Acquisition or Sale, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-3.1EX-3.1
EX-10.1EX-10.1
EX-99.1Completing Asset Acquisition or Sale, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-99.2Completing Asset Acquisition or Sale, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Reg. FD
EX-99.3Completing Asset Acquisition or Sale, Material Modifications to Rights of Security Holders, Amendments to Articles of Incorporation or Bylaws, Reg. FD
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic
GRAPHICGraphic